CDMO Expertise Across Therapeutics, Diagnostics, FoodTech, Veterinary, and Research Reagents
At Elise Biopharma, we serve a diverse and growing community of innovators across biologics, diagnostics, synthetic biology, and animal health. Our flexible microbial and mRNA-based CDMO platforms enable high-quality, scalable manufacturing that meets the specific needs of each application area. Whether you’re developing a life-saving therapeutic or scaling up a next-generation enzyme, our end-to-end support—from process development to regulatory documentation—helps you move quickly and confidently from bench to bioreactor.
Explore how we empower each sector below:
Therapeutics
From preclinical expression to GMP manufacturing — we enable next-generation biologics.
Elise Biopharma supports therapeutic developers across a wide range of modalities, including mRNA vaccines, antibody fragments, cytokines, and Fc-fusion proteins. Whether you’re developing a rare disease biologic or an oncology-targeted therapeutic, our platforms help reduce time to clinic while maximizing manufacturability.
We specialize in:
- mRNA vaccine payload production & capping
- Antibody fragments and bispecifics in E. coli or Pichia pastoris
- Recombinant cytokines for immuno-oncology
- Precision fermentation for rare-disease biologics
- IND-enabling process development and QC
Diagnostics
Speed, scalability, and consistency — built for the diagnostic supply chain.
We partner with diagnostic companies to manufacture recombinant enzymes, antigen proteins, and antibody fragments with high reproducibility and fast turnaround. Our infrastructure supports RUO, IVD, and early-stage diagnostic kit development, all under ISO 13485-aligned quality systems.
Diagnostic capabilities include:
- Enzyme fermentation & purification (e.g., Bst polymerases, RT, RNase inhibitors)
- Recombinant antigen production
- Antibody fragment production for lateral flow assays
- Endotoxin-controlled manufacturing
- ISO 13485-compliant QC and documentation
Food & Synthetic Biology
Fermentation-first solutions for the next wave of food and materials innovation.
From alternative proteins to precision-fermented biomaterials, Elise Biopharma supports synthetic biology companies seeking scalable, cost-efficient microbial manufacturing. Our services cover everything from strain engineering to techno-economic modeling for sustainable food and industrial biotech innovations.
Applications include:
- Recombinant caseins, whey proteins, and collagen
- Functional enzymes and flavor molecules
- Biopolymer and biomaterial precursors
- Fermentation process modeling and scale-up
- Cost modeling and sustainability optimization
Veterinary Biologics
High-quality biomanufacturing for animal health.
We provide agile CDMO support to veterinary biotech and animal health firms developing novel biologics for pets, livestock, aquaculture, and more. From vaccines and therapeutic enzymes to species-specific antibodies, our team ensures regulatory readiness and efficient production for USDA, EMA, and CVM pathways.
Veterinary CDMO services:
- Microbial expression of species-specific biologics
- Injectable and oral formulation development
- Scaled supply for field trials
- Cross-species QC method development
- Regulatory dossier support for USDA/EMA/CVM
Research Tools & Reagents
Rapid expression, scalable manufacturing — tailored for reagent companies.
We help reagent developers move from R&D to commercial production with high-yield expression platforms for proteins, enzymes, mRNA, and biosensor components. Our microbial and mRNA systems are designed for fast-turnaround, reproducibility, and cost-effective RUO-grade manufacturing.
Support for research tool developers:
- Recombinant protein expression with tag optimization
- mRNA synthesis for research-grade payloads
- Affinity reagents and biosensor components
- Custom fermentation development
- Fast-turnaround pilot lots for catalog reagents
Not Sure Where You Fit?
We know the biotech landscape is evolving rapidly—and not every program fits into a single category. If you’re working on something cross-modal, novel, or highly specific, we’re still here to help.